drugset / Trial / NCT00673595

Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo

NCT00673595

Terminated 19 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate endothelial function and autonomic regulation (for example, heart rate and blood pressure) in smokers before and after short-term smoking cessation. The endothelium is the thin layer of cells that lines the interior surface of blood vessels. The endothelium releases nitric oxide, which promotes dilation of the blood vessels and inhibits inflammation. Previous studies have shown that tobacco use is associated with endothelial dysfunction, and tobacco use increases heart rate and blood pressure. We hypothesize that 2 weeks of smoking cessation will improve endothelial function. We will also determine if endothelial function and autonomic regulation after short-term smoking cessation differs for patients that achieve abstinence with the smoking cessation agent varenicline compared to placebo.

Timeline

Start
2007-03
Primary completion
2009-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varenicline Small molecule 1 mg Oral

Indications

No indication recorded.